Aim
To produce a framework for the development of a qualitative semi‐structured interview guide.
Background
Rigorous data collection procedures fundamentally influence the results of studies. The ...semi‐structured interview is a common data collection method, but methodological research on the development of a semi‐structured interview guide is sparse.
Design
Systematic methodological review.
Data sources
We searched PubMed, CINAHL, Scopus and Web of Science for methodological papers on semi‐structured interview guides from October 2004–September 2014. Having examined 2,703 titles and s and 21 full texts, we finally selected 10 papers.
Review methods
We analysed the data using the qualitative content analysis method.
Results
Our analysis resulted in new synthesized knowledge on the development of a semi‐structured interview guide, including five phases: (1) identifying the prerequisites for using semi‐structured interviews; (2) retrieving and using previous knowledge; (3) formulating the preliminary semi‐structured interview guide; (4) pilot testing the guide; and (5) presenting the complete semi‐structured interview guide.
Conclusion
Rigorous development of a qualitative semi‐structured interview guide contributes to the objectivity and trustworthiness of studies and makes the results more plausible. Researchers should consider using this five‐step process to develop a semi‐structured interview guide and justify the decisions made during it.
Science Fiction Readership in India Abraham, Thomas; Dutta, Chandana
Indian literature (New Delhi),
02/2024, Volume:
68, Issue:
1 (339)
Journal Article
Drew Weissman, MD, PhD, received the 2023 Nobel Prize in Physiology or Medicine together with Katalin Karikó, PhD. Dr. Weissman received his bachelor's and master's degrees from Brandeis University, ...Waltham, MA, in 1981. He received his MD and PhD in 1987 from Boston University, Boston, MA, and this was followed by a residency at Beth Israel Deaconess Medical Center, Boston, MA. He then completed a fellowship at the National Institute of Allergy and Infectious Diseases under the supervision of Anthony Fauci, MD. He joined the Faculty at the University of Pennsylvania, Philadelphia, in 1997, where, in collaboration with Dr. Katalin Karikó, he explored the use of messenger RNA (mRNA) to drive heterologous gene expression in human cells. They overcame the notorious susceptibility of RNAs to degradation by packaging the mRNA in lipid nanoparticles and learned to both optimize protein expression and attenuate the inflammatory response to the exogenous RNAs by covalently modifying bases in the RNA sequence. This work has revolutionized immunization technology and allowed for the production of the most effective vaccines to prevent COVID-19.
PDF
